Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain
- PMID: 8879222
- PMCID: PMC2192814
- DOI: 10.1084/jem.184.4.1513
Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain
Abstract
Immunohistochemical methods were used to search for Fas receptor/Fas ligand system involvement in multiple sclerosis (MS) white matter brain lesions. We found large numbers of Fas ligand (Fas-L)-bearing cells present in two acute lesions and 12 of 16 chronic MS lesions, and very few positive cells in non-inflammatory controls. Four of six brains from non-MS neuropathologic conditions associated with inflammation and white matter disease were, however, also positive for Fas-L. Double staining with cell-specific markers revealed that the pattern of ligand-positive cells in chronic MS lesions was complex and composed of several different cell types which were primarily resident glial cells with a small overlay of macrophages. Fas/APO 1 (CD95) receptor expression in MS tissue was also evaluated and marked upregulation of the receptor was found. In addition, Fas receptor was induced, but to a lesser extent, in numerous control brains. The observations that TUNEL-positive dying cells were present in MS lesions and showed excellent co-localization with Fas-L, indicate that the Fas death system may contribute to plaque pathogenesis and could lead to the development of a new category of therapeutic agents for MS.
Similar articles
-
Multiple sclerosis: Fas signaling in oligodendrocyte cell death.J Exp Med. 1996 Dec 1;184(6):2361-70. doi: 10.1084/jem.184.6.2361. J Exp Med. 1996. PMID: 8976190 Free PMC article.
-
Up-regulated p75NTR neurotrophin receptor on glial cells in MS plaques.Neurology. 1999 Nov 10;53(8):1676-82. doi: 10.1212/wnl.53.8.1676. Neurology. 1999. PMID: 10563612
-
Fas (CD95/Apo-1)/Fas ligand expression in neonates with pontosubicular neuron necrosis.Pediatr Res. 2002 Feb;51(2):129-35. doi: 10.1203/00006450-200202000-00003. Pediatr Res. 2002. PMID: 11809905
-
On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.Leuk Lymphoma. 1998 Nov;31(5-6):477-90. doi: 10.3109/10428199809057607. Leuk Lymphoma. 1998. PMID: 9922038 Review.
-
[CD95 (APO-1/Fas) and CD95-ligand (CD95L). Implications of these apoptosis mediating receptor/ligand systems in the pathogenesis of autoimmune diseases].Verh Dtsch Ges Pathol. 1996;80:12-20. Verh Dtsch Ges Pathol. 1996. PMID: 9064994 Review. German.
Cited by
-
Interleukin 22 and its association with neurodegenerative disease activity.Front Pharmacol. 2022 Sep 13;13:958022. doi: 10.3389/fphar.2022.958022. eCollection 2022. Front Pharmacol. 2022. PMID: 36176437 Free PMC article. Review.
-
Up-regulation of Fas ligand (FasL) in the central nervous system: a mechanism of immune evasion by rabies virus.J Neurovirol. 2004 Dec;10(6):372-82. doi: 10.1080/13550280490521122. J Neurovirol. 2004. PMID: 15765808
-
Role of apoptosis in autoimmunity.J Clin Immunol. 2004 Jan;24(1):1-11. doi: 10.1023/B:JOCI.0000018057.89066.c6. J Clin Immunol. 2004. PMID: 14997028 Review.
-
Analysis of the cross-talk of Epstein-Barr virus-infected B cells with T cells in the marmoset.Clin Transl Immunology. 2017 Feb 10;6(2):e127. doi: 10.1038/cti.2017.1. eCollection 2017 Feb. Clin Transl Immunology. 2017. PMID: 28243437 Free PMC article.
-
Role of activated astrocytes in neuronal damage: potential links to HIV-1-associated dementia.Neurotox Res. 2005;7(3):183-92. doi: 10.1007/BF03036448. Neurotox Res. 2005. PMID: 15897153
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous